Back to Search
CORI AGARWAL, M.D.
M.D.
Plastic Surgery Physician
NPI: 1306978960IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Education
UNIVERSITY OF HAWAII JOHN A. BURNS SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
Fractionation of high molecular weight tannins in grape seed extract and identification of procyanidin B2-3,3'-di-O-gallate as a major active constituent causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells.
PMID 17331955·Carcinogenesis·2007
8-other
Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
PMID 17341659·Carcinogenesis·2007
8-other
Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells.
PMID 17172433·Mol Cancer Ther·2006
8-other
Anti-angiogenic efficacy of grape seed extract in endothelial cells.
PMID 14767522·Oncol Rep·2004
8-other
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
PMID 14614451·Oncogene·2003
8-other
Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release.
PMID 12419835·Carcinogenesis·2002
8-other
Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells.
PMID 19544333·Mol Carcinog·2010
8-other
Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products.
PMID 19640973·J Nutr·2009
6-review
p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.
PMID 19176374·Cancer Res·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- DIVISION OF PLASTIC SURGERY ADMINISTRATIVE OFFICE, 30 NORTH 1900 EAST 3B205
SALT LAKE CITY, UT 84132 - Phone
- (801) 585-6839
Quick Facts
- NPI
- 1306978960
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile